BEIJING, 14 novembre 2023 /PRNewswire/ — Récemment, en partenariat avec Hengxin Life Science & Technology Co., Ltd., Phabuilder Biotechnology Co., Ltd. a obtenu une commande de plusieurs millions de dollars américains, l’une des plus importantes de l’industrie du PHA à ce jour, qui vise…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.